Omics! Omics!

My friend and former colleague Ash Jogalekar tweeted out an interesting result recently , which is now expanded into a preprint. Using an in...

In my previous post about the Model Hardware Standard from Anthropic , I mentioned some exploration I've been running on instrument API...

Anthropic, the company behind Claude, announced a new initiative called the Model Hardware Standard (MHS).   It's a way to enable intell...

An interesting preprint showed up last week in the autonomous agent-driven experimentation space - an area I'm paid to be very intereste...

The Society for Industrial Microbiology (SIMB) annual meeting in Austin the first week of the month was great fun.  I caught up with two War...

PacBio had a major shakeup early this month. First came a large round of layoffs, which caught several individuals who were very much the fa...

I wish to highlight an interesting new preprint from a group at Danish Technical University which explores the schmutz in PCR reactions, d...

My father was a very methodical person, and that particularly applied when he decided to purchase the second IBM PC clone to appear on the m...

Last week news broke that Element Biosciences had won a patent lawsuit against Illumina, and that it affected MiSeq.  MiSeq????  How did a p...

A recent publication in Molecular Cell involving Fiber-Seq caught my attention, though I've since discovered this preprinted over a yea...

Okay, this is one of those cases where I kvetch about other people not having built the tools I want to use - perhaps a bit of a insufferabl...

I caught up by teleconference recently with Countable Labs CEO Giovanna Prout, fresh off Countable Labs' $26M equity fundraising - a rou...

An interesting news item this week is that BioNano Genomics has appointed Alex Hastie as Chief Scientific Officer.  Hastie is an obvious cho...

Another interesting preprint that fits several recent themes - genome minimization, discontinuation of products - comes from a Japanese grou...

There's an interesting new preprint from Jay Shendure's lab which introduces the technique of Shred-Seq, which is a Cas3-driven app...

Last week brought news that Standard Biotools, which is what Fluidigm morphed into, is being acquired by Treeline Biosciences, a drug develo...

Alexander Hoischen and colleagues have a brief piece in New England Journal of Medicine that published early this morning , in conjunction w...

The last bit of Craig Venter's career a followed, often a bit green with envy, was his work to build genomes.  This all revolved around ...

Few bombshells have hit genomics like the day in May 1998 when Craig Venter and Applied Biosystems announced he would be launching Celera Ge...

In the early 1990s, Craig Venter left the NIH over disputes around the patenting of ESTs.  Investors backed him, but then William Haseltine ...